The E2F transcription factor plays an important regulatory role in cel
l proliferation, mediating the expression of genes whose products are
essential for inducing resting cells to enter the cell cycle and synth
esize DNA. To investigate the possible involvement of E2F in hematopoi
etic malignancies, we isolated genomic clones encompassing the human E
2F1 gene. We then used fluorescence in situ hybridization to localize
E2F1 to human chromosome 20q11, telomeric to the p107 locus, a gene wh
ose product is related to the retinoblastoma gene product (pRb). This
finding contrasts with the 1p36 and 6q22 chromosomal locations previou
sly assigned E2F2 and E2F3, two additional members of the E2F family.
Although deletions or structural rearrangements of E2F1 were not detec
ted in 14 primary acute leukemia or myelodysplasia samples with struct
ural abnormalities of chromosome 20q11, the gene was amplified and ove
rexpressed in HEL erythroleukemia cells and translocated to other chro
mosomes in several established human leukemia cell lines. This study p
rovides the first evidence of gene amplification involving a member of
the E2F family of transcription factors. We propose that E2F1 overexp
ression in erythroid progenitors may stimulate abnormal cell prolifera
tion by overriding negative regulatory signals mediated by tumor suppr
essor proteins such as pRb. (C) 1995 Academic Press, Inc.